Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biogen Idec Senior VP International Business on Expanding Opportunities And Lessons Learned In Asia

This article was originally published in PharmAsia News

Executive Summary

Biogen Idec's strategy in emerging markets is not likely to change under the company's new CEO George Scangos, according to Senior VP International Business Gunther Winkler
Advertisement

Related Content

"With A Molecule That Is A Million Times Larger Than A Small Molecule, So Many Things Can Go Wrong," Says Biogen Idec Asia Operations Head Gunther Winkler
Biogen Set For Avonex Launch In India, But Concerned About Biosimilars Regulations
Biogen Set For Avonex Launch In India, But Concerned About Biosimilars Regulations
Advertisement
UsernamePublicRestriction

Register

SC073458

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel